Insider trade

Bright Minds Biosciences (DRUG)10% owner bought ~$923K

Cormorant Asset Management, 10% owner at Bright Minds Biosciences, bought ~$923K of Bright Minds Biosciences shares.

~$923K
Approx. value · 40K sh @ $23.22: 865K
Holds after · shares reported

Traded: Oct 16, 2024
Filed: Oct 17, 2024

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

Oct 15, 2024Insider · 1 personInsiders: 8 purchases (~$2.1M)
Oct 16, 2024 · this disclosureInsider10% owner purchased ~$923K of DRUG shares in the open market

What came next

Oct 16, 2024Insider · 1 personInsiders: 2 purchases (~$250K)
Nov 4, 2024Insider10% owner purchased ~$4M of DRUG shares in the open market

View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Bright Minds Biosciences

For Bright Minds Biosciences, OQRO holds 1 fund holdings report (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its DRUG page.

Other recent filings by Cormorant Asset Management, LP, 10% owner

The full history of Cormorant Asset Management, LP, 10% owner is on the profile page.

How this filing works

Other disclosures at Bright Minds Biosciences

Everything OQRO holds on this company is on its DRUG page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

Unlock OQRO Pro Already have an account? Log in

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data